Clinical trial
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed…
NCT00089050 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00089050 |
|---|---|
| Title | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia |
| Official title | A Phase II Trial Combining Gemtuzumab Ozogamicin (Mylotarg) With Cyclosporine for the Treatment of Relapsed Acute Myeloid Leukemia in Adults Over Age 60 |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cyclosporine, gemtuzumab ozogamicin |
| Start date | May 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Aug 5, 2004 |
| Last update posted | Nov 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: